STXS · Stereotaxis, Inc.
$1.33
+0.05 (+3.91%)
At close · Jul 29
Market Cap
$125.10M
Shares
97.74M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.28
Open$1.30
Day$1.24–1.31
52W$1.24–3.59
Avg vol 30d1.1M
Short int4.5M · 4.6% float · 6.7d
Short vol63%
Last earningsAug 11, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 13
Up next
Next earnings call
Aug 11, 2026
Scheduled
· in 2 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 13, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 18.2 · elevated
Equity put/call 0.71
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−41%
below
Price vs 50-day avg
−27%
below
RSI (14)
26
oversold
MACD trend
Negative
52-week position
2%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−26%
trailing
6-month return
−41%
trailing
YTD return
−44%
this year
Relative strength
−49%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow
Distributing
26 of 116 funds reported for Jun 30 · net -30.1K sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
4.56% of float · ▲ +4.6% MoM · 6.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
116 holders — near 3-yr high, broad support
Squeeze score
58
elevated · 0–100
Fundamentals
Revenue growth
−6%
Y/Y
Gross margin
58%
expanding
EPS growth
+17%
Y/Y
Balance sheet
$12.4M
net cash
Quant / Vol
risk profile
Volatility
55%
annualized · 1-yr
Max drawdown
−64%
past year
ATR
9.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Mar 31, 2026
Revenue from Synchrony
· this year
Initiated
$3M
prior FY $32.38M
midpoint −90.7% Y/Y
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−41%
Bearish
Price vs 50-day avg
−27%
Bearish
RSI (14)
26
Neutral
MACD trend
Negative
Bearish
52-week position
2%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow
Distributing
26 of 116 funds reported for Jun 30 · net -30.1K sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
4.56% of float · ▲ +4.6% MoM · 6.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
116 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $1
Now $1 · 2%
52-wk high $4
vs 200-day avg -41%
vs 50-day avg -27%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted operating expenses non-GAAP | $6.7M | first quarter of 2026 | — |
| Adjusted net loss non-GAAP | -$8.8M | full year 2025 | — |
| Adjusted operating loss non-GAAP | -$9.3M | full year 2025 | — |
| System backlog | $9.1M | the start of 2026 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
STXS
this stock
Stereotaxis, Inc.
|
$125.10M | -44.3% | -5.8% | — | 4.6% |
|
ISRG
Intuitive Surgical Inc
|
$127.82B | -36.1% | +20.5% | 41.5 | 1.9% |
|
MDLN
Medline Inc.
|
$53.22B | -3.5% | +11.5% | — | 2.2% |
|
BDX
Becton Dickinson & Co
|
$45.83B | +10.5% | +8.2% | 63.2 | 3.8% |
|
ALC
Alcon Inc
|
$33.70B | -12.3% | +10.5% | — | 2.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| STXS | -12.9% | -26.0% | -41.3% | -25.6% | -44.4% |
| SPY | -1.0% | 0.0% | +7.4% | -0.8% | +8.6% |
| vs SPY | -11.9% | -26.0% | -48.7% | -24.8% | -53.0% |
Key facts
CIK
1289340
CUSIP
85916J409
13F (30d)
22 filings
22 filers
Visit website
Investor relations